These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
247 related articles for article (PubMed ID: 21883880)
1. Differential contributions of monocyte- and platelet-derived microparticles towards thrombin generation and fibrin formation and stability. Aleman MM; Gardiner C; Harrison P; Wolberg AS J Thromb Haemost; 2011 Nov; 9(11):2251-61. PubMed ID: 21883880 [TBL] [Abstract][Full Text] [Related]
2. Platelet- and erythrocyte-derived microparticles trigger thrombin generation via factor XIIa. Van Der Meijden PE; Van Schilfgaarde M; Van Oerle R; Renné T; ten Cate H; Spronk HM J Thromb Haemost; 2012 Jul; 10(7):1355-62. PubMed ID: 22537188 [TBL] [Abstract][Full Text] [Related]
3. Increased blood cell phosphatidylserine exposure and circulating microparticles contribute to procoagulant activity after carotid artery stenting. Zhao L; Wu X; Si Y; Yao Z; Dong Z; Novakovic VA; Guo L; Tong D; Chen H; Bi Y; Kou J; Shi H; Tian Y; Hu S; Zhou J; Shi J J Neurosurg; 2017 Nov; 127(5):1041-1054. PubMed ID: 28009236 [TBL] [Abstract][Full Text] [Related]
4. Platelet-derived microparticles trigger THP-1 monocytic cell aggregation and release of pro-coagulant tissue factor-expressing microparticles in vitro. Lin HC; Chang HW; Hsiao SH; Chou ML; Seghatchian J; Burnouf T Transfus Apher Sci; 2015 Oct; 53(2):246-52. PubMed ID: 26597313 [TBL] [Abstract][Full Text] [Related]
5. Activity of Tissue Factor in Microparticles Produced in vitro by Endothelial Cells, Monocytes, Granulocytes, and Platelets. Khaspekova SG; Antonova OA; Shustova ON; Yakushkin VV; Golubeva NV; Titaeva EV; Dobrovolsky AB; Mazurov AV Biochemistry (Mosc); 2016 Feb; 81(2):114-21. PubMed ID: 27260391 [TBL] [Abstract][Full Text] [Related]
6. Phosphatidylserine exposing-platelets and microparticles promote procoagulant activity in colon cancer patients. Zhao L; Bi Y; Kou J; Shi J; Piao D J Exp Clin Cancer Res; 2016 Mar; 35():54. PubMed ID: 27015840 [TBL] [Abstract][Full Text] [Related]
7. Increased phosphatidylserine-exposing microparticles and their originating cells are associated with the coagulation process in patients with IgA nephropathy. He Z; Zhang Y; Cao M; Ma R; Meng H; Yao Z; Zhao L; Liu Y; Wu X; Deng R; Dong Z; Bi Y; Kou J; Novakovic V; Shi J; Hao L Nephrol Dial Transplant; 2016 May; 31(5):747-59. PubMed ID: 26673909 [TBL] [Abstract][Full Text] [Related]
8. Potential Involvement of Platelet-Derived Microparticles and Microparticles Forming Immune Complexes during Monocyte Activation in Patients with Systemic Lupus Erythematosus. Burbano C; Villar-Vesga J; Orejuela J; Muñoz C; Vanegas A; Vásquez G; Rojas M; Castaño D Front Immunol; 2018; 9():322. PubMed ID: 29545790 [TBL] [Abstract][Full Text] [Related]
9. Endothelial, platelet, and tissue factor-bearing microparticles in cancer patients with and without venous thromboembolism. Campello E; Spiezia L; Radu CM; Bulato C; Castelli M; Gavasso S; Simioni P Thromb Res; 2011 May; 127(5):473-7. PubMed ID: 21256535 [TBL] [Abstract][Full Text] [Related]
10. The Release of Monocyte-Derived Tissue Factor-Positive Microparticles Contributes to a Hypercoagulable State in Idiopathic Membranous Nephropathy. Wang GH; Lu J; Ma KL; Zhang Y; Hu ZB; Chen PP; Lu CC; Zhang XL; Liu BC J Atheroscler Thromb; 2019 Jun; 26(6):538-546. PubMed ID: 30429407 [TBL] [Abstract][Full Text] [Related]
11. Procoagulant microparticles promote coagulation in a factor XI-dependent manner in human endotoxemia. Mooberry MJ; Bradford R; Hobl EL; Lin FC; Jilma B; Key NS J Thromb Haemost; 2016 May; 14(5):1031-42. PubMed ID: 26857798 [TBL] [Abstract][Full Text] [Related]
12. Factor VIIa-mediated tenase function on activated platelets under flow. Goel MS; Diamond SL J Thromb Haemost; 2004 Aug; 2(8):1402-10. PubMed ID: 15304047 [TBL] [Abstract][Full Text] [Related]
13. Activated Platelet-Derived and Leukocyte-Derived Circulating Microparticles and the Risk of Thrombosis in Heparin-Induced Thrombocytopenia: A Role for PF4-Bearing Microparticles? Campello E; Radu CM; Duner E; Lombardi AM; Spiezia L; Bendo R; Ferrari S; Simioni P; Fabris F Cytometry B Clin Cytom; 2018 Mar; 94(2):334-341. PubMed ID: 28052584 [TBL] [Abstract][Full Text] [Related]
14. [THROMBIN-MEDIATED EFFECTS OF BLOOD MICROPARTICLES ON FORMATION, STRUCTURE, AND STABILITY OF FIBRIN CLOTS]. Nabiullina RM; Mustafin IG; Ataullakhanov FI; Litvinov RI; Zubairova LD Ross Fiziol Zh Im I M Sechenova; 2015 Jul; 101(7):812-21. PubMed ID: 26591054 [TBL] [Abstract][Full Text] [Related]
15. Microparticle-associated tissue factor activity in patients with metastatic pancreatic cancer and its effect on fibrin clot formation. Thaler J; Koder S; Kornek G; Pabinger I; Ay C Transl Res; 2014 Feb; 163(2):145-50. PubMed ID: 23973167 [TBL] [Abstract][Full Text] [Related]
16. Microparticle-associated tissue factor activity is reduced by inhibition of the complement protein 5 in Neisseria meningitidis-exposed whole blood. Øvstebø R; Hellum M; Aass HC; Trøseid AM; Brandtzaeg P; Mollnes TE; Henriksson CE Innate Immun; 2014 Jul; 20(5):552-60. PubMed ID: 24051102 [TBL] [Abstract][Full Text] [Related]
17. Use of Thrombodynamics for revealing the participation of platelet, erythrocyte, endothelial, and monocyte microparticles in coagulation activation and propagation. Lipets EN; Antonova OA; Shustova ON; Losenkova KV; Mazurov AV; Ataullakhanov FI PLoS One; 2020; 15(5):e0227932. PubMed ID: 32469873 [TBL] [Abstract][Full Text] [Related]
18. The composition and daily variation of microparticles in whole blood in stable coronary artery disease. Christersson C; Lindahl B; Siegbahn A Scand J Clin Lab Invest; 2016; 76(1):25-32. PubMed ID: 26405844 [TBL] [Abstract][Full Text] [Related]